TY - JOUR
T1 - Propensity-matched comparison of percutaneous and surgical cut-down approaches in transfemoral transcatheter aortic valve implantation using a balloon-expandable valve
AU - Kawashima, Hideyuki
AU - Watanabe, Yusuke
AU - Kozuma, Ken
AU - Nara, Yugo
AU - Hioki, Hirofumi
AU - Kataoka, Akihisa
AU - Yamamoto, Masanori
AU - Takagi, Kensuke
AU - Araki, Motoharu
AU - Tada, Norio
AU - Shirai, Shinichi
AU - Yamanaka, Futoshi
AU - Hayashida, Kentaro
PY - 2017/3
Y1 - 2017/3
N2 - Aims: This study aimed to compare the clinical outcomes of patients undergoing transfemoral transcatheter aortic valve implantation (TAVI) via a percutaneous or surgical cut-down approach. Methods and results: Between October 2013 and July 2015, 586 patients underwent transfemoral TAVI according to the Optimized CathEter vAlvular iNtervention (OCEAN)-TAVI registry (percutaneous approach, n=305; surgical cut-down approach, n=281). After propensity matching, 166 patients underwent transfemoral TAVI via each approach. Major vascular complications, as defined per the Valve Academic Research Consortium-2 criteria, were found less frequently in patients who underwent a percutaneous approach (15.1% vs. 27.1%, p<0.01), and femoral artery injuries requiring surgical repair were mostly the result of a closure device failure (seven cases, 4.2%). In these patients, major bleeding was less (7.2% vs. 16.9%, p=0.01) and blood transfusion less frequent (21.1% vs. 38.0%, p<0.01); therefore, cases of acute kidney injury (AKI) were rare (6.0% vs. 15.1%, p<0.01). Conclusions: Transfemoral TAVI using the percutaneous approach proved safe and feasible and resulted in fewer major vascular complications, bleeding and AKI events compared to the surgical cut-down approach.
AB - Aims: This study aimed to compare the clinical outcomes of patients undergoing transfemoral transcatheter aortic valve implantation (TAVI) via a percutaneous or surgical cut-down approach. Methods and results: Between October 2013 and July 2015, 586 patients underwent transfemoral TAVI according to the Optimized CathEter vAlvular iNtervention (OCEAN)-TAVI registry (percutaneous approach, n=305; surgical cut-down approach, n=281). After propensity matching, 166 patients underwent transfemoral TAVI via each approach. Major vascular complications, as defined per the Valve Academic Research Consortium-2 criteria, were found less frequently in patients who underwent a percutaneous approach (15.1% vs. 27.1%, p<0.01), and femoral artery injuries requiring surgical repair were mostly the result of a closure device failure (seven cases, 4.2%). In these patients, major bleeding was less (7.2% vs. 16.9%, p=0.01) and blood transfusion less frequent (21.1% vs. 38.0%, p<0.01); therefore, cases of acute kidney injury (AKI) were rare (6.0% vs. 15.1%, p<0.01). Conclusions: Transfemoral TAVI using the percutaneous approach proved safe and feasible and resulted in fewer major vascular complications, bleeding and AKI events compared to the surgical cut-down approach.
UR - http://www.scopus.com/inward/record.url?scp=85016115154&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85016115154&partnerID=8YFLogxK
U2 - 10.4244/EIJ-D-16-00408
DO - 10.4244/EIJ-D-16-00408
M3 - Article
C2 - 27746402
AN - SCOPUS:85016115154
VL - 12
SP - 1954
EP - 1961
JO - EuroIntervention
JF - EuroIntervention
SN - 1774-024X
IS - 16
ER -